Channels - Impact of different PSMA PET-based eligibility criteria on outcome of [Lu]Lu-PSMA radioligand therapy using [F]rhPSMA-7/[F]rhPSMA-7.3 (Flotufolastat)

Similar Items: Impact of different PSMA PET-based eligibility criteria on outcome of [Lu]Lu-PSMA radioligand therapy using [F]rhPSMA-7/[F]rhPSMA-7.3 (Flotufolastat)

Quick Look
Outcome after primary directed radiotherapy in predominantly PSMA-PET/CT-staged patients with metastatic prostate cancer
Quick Look
Can chatGPT-4o reliably standardize PSMA PET/CT and PET/MRI reports using PROMISE V2 criteria? - An exploratory study
Quick Look
18F-PSMA-1007 in recurrent prostate cancer, a new frontier in prostate cancer PET imaging
Quick Look
Integrated Ga-PSMA PET/MRI models improve prostate cancer diagnosis and ISUP stratification, especially in the low-PSA cohort
Quick Look
Prostate specific membrane antigen (PSMA) targeting polymer-peptide conjugates
Quick Look
Metastatic Merkel Cell Carcinoma Incidentally Detected on PSMA PET/CT in a Patient With Metastatic Prostate Cancer
Quick Look
PSMA PET/CT Incidental Detection of Tumor Thrombus From Unsuspected Renal Cell Carcinoma and Comparison with FDG PET/CT
Quick Look
Optimizing PSMA scintigraphy for resource limited settings – a retrospective comparative study
Quick Look
[68Ga]Ga‐PSMA‐11 PET/CT for baseline staging of high‐risk prostate cancer: A real‐world study
Quick Look
A novel polyester–drug nanoconjugate with subtype selectivity for high efficacy against PSMA-positive prostate cancer
Quick Look
Long-term outcomes in medullary thyroid cancer patients treated with [Lu]Lu-DOTAGA.FAPi dimer therapy
Quick Look
MRI and 18F-fluorothymidine PET-MR for the early evaluation of renal and bone marrow effects in 177Lu-DOTATATE therapy
Quick Look
Evaluating the role of a 99mTc-HYNIC-PSMA SPECT scan following a negative bone scan in men with prostate cancer: a single-centre, retrospective cohort study
Quick Look
Can clinicians predict individual patient outcomes in neuroendocrine tumors treated with [177Lu]Lu-DOTATATE?
Quick Look
The contribution of His7.36(305) of the GnRH receptor to ligand binding and receptor activation
Quick Look
Dual-time-point [F]FDG-PET/CT as a prognostic biomarker in patients with pleural mesothelioma undergoing immunotherapy
Quick Look
Cloning and characterisation of gonadotropin-releasing hormone (GnRH) receptors in the cichlid (Haplochromis burtoni) and the zebrafish (Danio rerio)
Quick Look
Reconstruction matters: influence of EARL standards and BSREM in [F]FET PET for distinguishing glioma progression from treatment-related changes
Quick Look
Toward reproducible metabolic tumor volume quantification in endometrial cancer: optimizing [¹⁸F]FDG PET/CT tumor segmentation methods
Quick Look
Crosstalk between steroid and GnRH receptors in regulating gene expression in the mouse LÇT2 gonadotrope cell line
Quick Look
Preoperative assessment of IDH status in adult glioma by integrated F-FET PET/MR fusion: a comparative analysis of fusion algorithms
Quick Look
Subcutaneous injection of semaglutide causes increased muscle uptake of F-FDG and reduces the imaging quality of PET/CT: a case report
Quick Look
[F]FDG PET/CT is a quantitative tool to probe vascular inflammation and immune system metabolic activation in atherosclerotic nonhuman primates
Quick Look
Head to head comparison of [Ga]Ga-FAPI-04 and [F]FDG PET/CT in the diagnosis and staging of pancreatic cancer: a prospective study